Loading...

Akumin Inc.

AKU•NASDAQ
Healthcare
Medical - Diagnostics & Research
$0.29
$-0.06(-17.87%)

Akumin Inc. (AKU) Stock Overview

Explore Akumin Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 63.5/100

Key Financials

Market Cap26.3M
P/E Ratio-0.17
EPS (TTM)$-2.19
ROE-5.32%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$0.10

AKU Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Akumin Inc. (AKU) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.10.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.17 and a market capitalization of 26.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;